Dongsheng Zhang - Search Results

Year	Number of Results
1999	1
2000	1
2002	7
2003	6
2004	7
2005	6
2006	10
2007	14
2008	9
2009	12
2010	12
2011	25
2012	23
2013	30
2014	39
2015	35
2016	41
2017	34
2018	35
2019	44
2020	43
2021	52
2022	58
2023	26

1

USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer.

Shi D, Wu X, Jian Y, Wang J, Huang C, Mo S, Li Y, Li F, Zhang C, Zhang D, Zhang H, Huang H, Chen X, Wang YA, Lin C, Liu G, Song L, Liao W. Shi D, et al. Among authors: zhang d. Nat Commun. 2022 Sep 26;13(1):5644. doi: 10.1038/s41467-022-33285-x. Nat Commun. 2022. PMID: 36163134 Free PMC article.

2

2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy.

Zhang D, Li J, Wang F, Hu J, Wang S, Sun Y. Zhang D, et al. Cancer Lett. 2014 Dec 28;355(2):176-83. doi: 10.1016/j.canlet.2014.09.003. Epub 2014 Sep 10. Cancer Lett. 2014. PMID: 25218591 Review.

3

Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression.

Yang E, Wang X, Gong Z, Yu M, Wu H, Zhang D. Yang E, et al. Among authors: zhang d. Signal Transduct Target Ther. 2020 Oct 19;5(1):242. doi: 10.1038/s41392-020-00359-5. Signal Transduct Target Ther. 2020. PMID: 33077737 Free PMC article. Review.

4

The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p.

Chen DL, Sheng H, Zhang DS, Jin Y, Zhao BT, Chen N, Song K, Xu RH. Chen DL, et al. Mol Cancer. 2021 Dec 15;20(1):166. doi: 10.1186/s12943-021-01475-8. Mol Cancer. 2021. PMID: 34911533 Free PMC article.

5

Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis.

Wang F, He MM, Yao YC, Zhao X, Wang ZQ, Jin Y, Luo HY, Li JB, Wang FH, Qiu MZ, Lv ZD, Wang DS, Li YH, Zhang DS, Xu RH. Wang F, et al. Cell Rep Med. 2021 Aug 27;2(9):100383. doi: 10.1016/j.xcrm.2021.100383. eCollection 2021 Sep 21. Cell Rep Med. 2021. PMID: 34622226 Free PMC article. Clinical Trial.

6

The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors.

Jin Y, Chen DL, Wang F, Yang CP, Chen XX, You JQ, Huang JS, Shao Y, Zhu DQ, Ouyang YM, Luo HY, Wang ZQ, Wang FH, Li YH, Xu RH, Zhang DS. Jin Y, et al. Mol Cancer. 2020 Oct 30;19(1):154. doi: 10.1186/s12943-020-01274-7. Mol Cancer. 2020. PMID: 33126883 Free PMC article.

7

A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study).

Wang F, He MM, Xiao J, Zhang YQ, Yuan XL, Fang WJ, Zhang Y, Wang W, Hu XH, Ma ZG, Yao YC, Zhuang ZX, Zhou FX, Ying JE, Yuan Y, Zou QF, Guo ZQ, Wu XY, Jin Y, Mai ZJ, Wang ZQ, Qiu H, Guo Y, Shi SM, Chen SZ, Luo HY, Zhang DS, Wang FH, Li YH, Xu RH. Wang F, et al. Clin Cancer Res. 2022 Oct 3;28(19):4232-4239. doi: 10.1158/1078-0432.CCR-22-0655. Clin Cancer Res. 2022. PMID: 35929990 Free PMC article. Clinical Trial.

8

Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac⁴C acetylation of KIF23 mRNA.

Jin C, Wang T, Zhang D, Yang P, Zhang C, Peng W, Jin K, Wang L, Zhou J, Peng C, Tan Y, Ji J, Chen Z, Sun Q, Yang S, Tang J, Feng Y, Sun Y. Jin C, et al. Among authors: zhang d. J Exp Clin Cancer Res. 2022 Dec 15;41(1):345. doi: 10.1186/s13046-022-02551-7. J Exp Clin Cancer Res. 2022. PMID: 36522719 Free PMC article.

9

ME1 Regulates NADPH Homeostasis to Promote Gastric Cancer Growth and Metastasis.

Lu YX, Ju HQ, Liu ZX, Chen DL, Wang Y, Zhao Q, Wu QN, Zeng ZL, Qiu HB, Hu PS, Wang ZQ, Zhang DS, Wang F, Xu RH. Lu YX, et al. Cancer Res. 2018 Apr 15;78(8):1972-1985. doi: 10.1158/0008-5472.CAN-17-3155. Cancer Res. 2018. PMID: 29654155

10

CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway.

Yang P, Zhang D, Wang T, Ji J, Jin C, Peng C, Tan Y, Zhou J, Wang L, Feng Y, Sun Y. Yang P, et al. Among authors: zhang d. Cell Death Dis. 2022 Sep 19;13(9):796. doi: 10.1038/s41419-022-05240-7. Cell Death Dis. 2022. PMID: 36123327 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

508 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

508 results

Results by year